Market Overview

Oppenheimer Holdings Reiterates Outperform Rating, $23 PT on Prestige Brands Holdings

Related PBH
Top 4 Stocks In The Medical Equipment Wholesale Industry With The Highest Gross Margin
Cardinal Health Purchases The Harvard Drug Group For $1.115 Billion

In a report published Wednesday, Oppenheimer Holdings reiterated its Outperform rating and $23.00 price target on Prestige Brands Holdings (NYSE: PBH).

Oppenheimer Holdings noted, “Our recent meeting with Prestige Brands' senior management reinforced our belief that the company continues to execute on its three-pronged growth strategy, which should drive double-digit EPS growth even without the benefit of acquisitions. We would continue to be buyers of the shares and reiterate both our Outperform rating and DCF-derived $23 target price.”

Prestige Brands Holdings closed on Tuesday at $19.96.

Latest Ratings for PBH

Aug 2015JefferiesMaintainsHold
Feb 2015Raymond JamesDowngradesOutperformMarket Perform
Jan 2015JefferiesMaintainsHold

View More Analyst Ratings for PBH
View the Latest Analyst Ratings

Posted-In: Oppenheimer HoldingsAnalyst Color Reiteration Analyst Ratings


Related Articles (PBH)

View Comments and Join the Discussion!

Get Benzinga's Newsletters